NAFDAC, WHO certify Covidshield vaccine as AstraZeneca’s patent

National Agency for Food and Drug Administration and Control (NAFDAC) and the World Health Organisation (WHO) have confirmed Covidshield vaccine as same AstraZeneca/Oxford University jab produced commercially in India.

Chukwuma Muanya

Latest news today on NAFDAC

NAFDAC, WHO certify Covidshield vaccine as AstraZeneca’s patent

Watchout for original Astrazeneca vaccine labels, NAFDAC tells Nigerians

NAFDAC destroys N2bn worth of medicines, cosmetics in Awka, Kano

Anxiety as more European nations suspend COVID-19 vaccine

Anxiety over fake COVID-19 vaccines

NAFDAC destroys N613m counterfeit goods in Kano

States yet to meet conditions won’t receive COVID-19 vaccines, says FG

At last, FG takes delivery of COVID-19 vaccines

NAFDAC has made progress with COVID-19 intervention fund – DG

NAFDAC to shut down packaged water factories endangering health of Nigerians

Consumers commission partners NAFDAC on COVID-19 vaccine information

Experts fault NAFDAC on emergency approval for Oxford, AstraZeneca vaccine

NAFDAC approves AstraZeneca COVID-19 vaccine

Concerns as new COVID-19 variants emerge

How food, drug companies can take advantage of AfCFTA , by NAFDAC

NAFDAC seals 13 fake dairies and water factories in Kano – official

NAFDAC reads riot act to importers, clearing agents

Nigeria lacks capacity for COVID-19 vaccine trials, say experts

Unusual Valentine’s Day amid pandemic

Shettima returns, pushes Nigeria’s economic interests at BRICS Summit.

Delta NDLEA seizes drugs worth over ₦2bn, destroys 36.2 hectares of cannabis farms

Aduke returns with ‘Aralamo’, brings Yoruba storytelling into a new musical chapter

Olubadan seeks more corporate support for a, economic growth

The News You Need, Delivered To You.